Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 22, which means every article in Journal of Vaccines & Vaccination has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.

  2022 2021 2020 2019 2018

Year wise published articles

59 65 71 11 19

Year wise citations received

174 249 218 197 194
Journal total citations count 2051
Journal Impact Factor 2.87
Journal 5 years Impact Factor 3.73
Journal CiteScore 4.69
Journal h-index 22
Important citations

B Cell Epitope-Based Vaccination Therapy

B-cell populations are expanded in breast cancer patients compared with healthy controls.

Syntheses and Functional Studies of Self-Adjuvanting Anti-HER2 Cancer Vaccines.

Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates.

RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination

Novel Aspects and Strategies in Vaccination

MVA85A vaccine to enhance BCG for preventing tuberculosis

Mechanistic approach of drug discovery from natural substances for thrombocytopenia: A major cause of death in dengue fever patients

RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination

Novel Aspects and Strategies in Vaccination

A Mini Review: Ethical Usage of Animals in Pharmacological Research

TETRAVALENT DENGUE VACCINE: CHILDREN/ADOLESCENTS IN BRAZIL Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9-16 Years in Brazil

Seguridad e inmunogenicidad en ensayos clínicos de vacunas para Dengue

An insight into dengue virus proteins as potential drug/vaccine targets

Dengue Fever: Symptoms, Treatments and Prevention; A General Perspective

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: Randomised phase II study in US adults

Anti-dengue Vaccines: From Development to Clinical Trials.

Zika Virus (ZIKV) Infection: A Review

Ancient Diseases-Microbial Impact

Efficacy of tetravalent dengue vaccine in Thai schoolchildren – Authors' reply